Medifast, Inc. (MED)
USD 17.77
(-4.41%)
USD 17.77
(-4.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 147.65 Million | 194.57 Million | 94.54 Million | 145.19 Million | 84.26 Million | 60.81 Million |
| Net Income | 99.41 Million | 143.56 Million | 164.03 Million | 102.85 Million | 77.91 Million | 55.78 Million |
| Depreciation & Amortization | 13.1 Million | 10.98 Million | 6.81 Million | 7.27 Million | 4.62 Million | 4.43 Million |
| Deferred income taxes | 1.21 Million | -924 Thousand | -3.71 Million | 601 Thousand | 1.59 Million | -2.68 Million |
| Stock-based compensation | 8.18 Million | 11.05 Million | 9.9 Million | 6.79 Million | 4.52 Million | 3.12 Million |
| Change in working capital | 20.27 Million | 21.65 Million | -87.64 Million | 26.58 Million | -8.5 Million | -467 Thousand |
| Other non-cash items | 5.46 Million | 8.24 Million | 5.16 Million | 1.08 Million | 4.1 Million | 622 Thousand |
| Investing Cash Flow | -61.04 Million | -11.41 Million | -29.06 Million | -1.28 Million | -6.32 Million | -1.19 Million |
| Investments in PPE | -6.48 Million | -16.68 Million | -34.2 Million | -5.88 Million | -10.05 Million | -4.94 Million |
| Acquisitions | - | - | - | - | - | 196 Thousand |
| Investment purchases | -54.56 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | 5.26 Million | 5.14 Million | 4.6 Million | 3.73 Million | 3.54 Million |
| Other Investing Activities | -54.56 Million | 5.26 Million | 5.14 Million | 4.6 Million | 3.73 Million | 196 Thousand |
| Financing Cash Flow | -79.78 Million | -199.58 Million | -125.13 Million | -57.14 Million | -82.32 Million | -53.32 Million |
| Debt repayment | -188 Thousand | - | -811 Thousand | -1.59 Million | -278 Thousand | - |
| Dividends payments | -73.01 Million | -71.62 Million | -63.85 Million | -53.19 Million | -35.39 Million | -23.16 Million |
| Common Stock Repurchased | -6.96 Million | -127.96 Million | -62.08 Million | -5.55 Million | -47.2 Million | -30.71 Million |
| Common Stock Issuance | 188 Thousand | - | 811 Thousand | 1.59 Million | 278 Thousand | 547 Thousand |
| Other Financing Activities | 188 Thousand | -127.96 Million | 811 Thousand | 1.59 Million | 278 Thousand | 547 Thousand |
| Accounts receivables | 873 Thousand | 37.59 Million | -54.38 Million | 297 Thousand | -4.06 Million | 122 Thousand |
| Accounts payables | -35.7 Million | -37.59 Million | 54.38 Million | 25.73 Million | 10.61 Million | 15.79 Million |
| Inventory | 64.26 Million | 61.18 Million | -126.65 Million | -4.62 Million | -9.88 Million | -18.65 Million |
| Other working capital | -9.15 Million | -39.53 Million | 39 Million | 5.16 Million | -5.16 Million | 2.27 Million |
| Cash at beginning of period | 87.69 Million | 104.18 Million | 163.72 Million | 76.97 Million | 81.36 Million | 75.07 Million |
| Cash at end of period | 94.44 Million | 87.69 Million | 104.18 Million | 163.72 Million | 76.97 Million | 81.36 Million |
| Capital Expenditure | -6.48 Million | -16.68 Million | -34.2 Million | -5.88 Million | -10.05 Million | -4.94 Million |
| Effect of forex changes on cash | -72 Thousand | -67 Thousand | 112 Thousand | -21 Thousand | 1000.00 | -2000.00 |
| Net cash flow / Change in cash | 6.74 Million | -16.49 Million | -59.54 Million | 86.74 Million | -4.39 Million | 6.28 Million |
| Free Cash Flow | 141.17 Million | 177.88 Million | 60.33 Million | 139.3 Million | 74.2 Million | 55.87 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.12 Million | -8.15 Million | 8.31 Million | 99.41 Million | 6.03 Million | 23.13 Million |
| Depreciation & Amortization | 2.08 Million | 3.06 Million | 4.36 Million | 13.1 Million | 3.35 Million | 3.41 Million |
| Deferred income taxes | 106 Thousand | -103 Thousand | 112 Thousand | 1.21 Million | 6.7 Million | -6.29 Million |
| Stock-based compensation | 606 Thousand | 2.45 Million | 2.17 Million | 8.18 Million | 2.39 Million | 2.67 Million |
| Change in working capital | 6.04 Million | -984 Thousand | -5.06 Million | 20.27 Million | -9.27 Million | 5.98 Million |
| Other non-cash items | -900 Thousand | 22.21 Million | 15.88 Million | 5.46 Million | 1.3 Million | 1.02 Million |
| Investing Cash Flow | -1.78 Million | -2.53 Million | -2.77 Million | -61.04 Million | -10.73 Million | -46.45 Million |
| Investments in PPE | -1.39 Million | -1.93 Million | -1.84 Million | -6.48 Million | -946 Thousand | -1.67 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -6.7 Million | -8.47 Million | -9.16 Million | -54.56 Million | -9.78 Million | -44.77 Million |
| Sales/Maturities of investments | 6.23 Million | 7.88 Million | 8.23 Million | - | - | - |
| Other Investing Activities | 81.99 Thousand | -594 Thousand | -934 Thousand | -54.56 Million | -9.78 Million | -44.77 Million |
| Financing Cash Flow | -3000.00 | -20 Thousand | -1.49 Million | -79.78 Million | -17.9 Million | -18.15 Million |
| Debt repayment | - | - | - | -188 Thousand | -83 Thousand | - |
| Dividends payments | -1000.00 | -4000.00 | -710 Thousand | -73.01 Million | -17.97 Million | -18.04 Million |
| Common Stock Repurchased | 833 Thousand | -16 Thousand | -817 Thousand | -6.96 Million | -10 Thousand | -110 Thousand |
| Common Stock Issuance | -36 Thousand | - | 36 Thousand | 188 Thousand | 83 Thousand | - |
| Other Financing Activities | -799 Thousand | - | 36 Thousand | 188 Thousand | 83 Thousand | -110 Thousand |
| Accounts receivables | - | - | - | 873 Thousand | - | - |
| Accounts payables | -4.34 Million | -3.51 Million | -15.91 Million | -35.7 Million | -364 Thousand | -3.49 Million |
| Inventory | -492 Thousand | 6.67 Million | 8.31 Million | 64.26 Million | 3.63 Million | 10.66 Million |
| Other working capital | 1.6 Million | -4.14 Million | 2.53 Million | -9.15 Million | -12.54 Million | -1.19 Million |
| Cash at beginning of period | 108.01 Million | 97.47 Million | 94.44 Million | 87.69 Million | 112.75 Million | 147.4 Million |
| Cash at end of period | 115.3 Million | 108.01 Million | 97.47 Million | 94.44 Million | 94.44 Million | 112.75 Million |
| Capital Expenditure | -1.39 Million | -1.93 Million | -1.84 Million | -6.48 Million | -946 Thousand | -1.67 Million |
| Effect of forex changes on cash | -43 Thousand | 28 Thousand | 15 Thousand | -72 Thousand | -197 Thousand | 26 Thousand |
| Net cash flow / Change in cash | 7.29 Million | 10.54 Million | 3.03 Million | 6.74 Million | -18.31 Million | -34.65 Million |
| Free Cash Flow | 7.68 Million | 11.13 Million | 5.44 Million | 141.17 Million | 9.57 Million | 28.25 Million |
0MN5
688268
OCLG
CPHI
JEGI
2791